{"database": "lobbying", "table": "lobbying_activities", "rows": [[1260654, "bdd45747-b59c-495d-8596-8f713efb7291", "Q2", "DENNY MILLER ASSOCIATES", 25328, "CELL THERAPEUTICS", 2012, "second_quarter", "MED", "S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2012-07-11T16:22:16.397000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1260654"], "units": {}, "query_ms": 37.26330690551549, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}